Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Lung Neoplasms 2Liver Neoplasms 2Carcinoma, Hepatocellular 2Solitary Pulmonary Nodule 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1Bronchial Neoplasms 1

Interventions

Sorafenib 202lenvatinib 129Bevacizumab 124Nivolumab 85pembrolizumab 72atezolizumab 72Radiosurgery 71durvalumab 63Oxaliplatin 59sintilimab 57Fluorouracil 54Doxorubicin 44tislelizumab 43apatinib 43Leucovorin 40tremelimumab 37camrelizumab 37Radiofrequency Ablation 37Radiotherapy 36Magnetic Resonance Spectroscopy 32Capecitabine 30regorafenib 29Folfox protocol 29Cisplatin 28cabozantinib 26Hepatectomy 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25toripalimab 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Hepatocellular × Technetium Tc 99m Aggregated Albumin × Clear all
NCT03028311 2026-03-10

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
12 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05848947 2025-01-29

MAApping

Sirtex Medical

Phase 4 Completed
5 enrolled 9 charts
Gastrointestinal

Carcinoma, Carcinoma, Hepatocellular, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡